| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Life Science REIT plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.39 |
| 52 Week High | UK£0.86 |
| 52 Week Low | UK£0.39 |
| Beta | 0.12 |
| 1 Month Change | -9.22% |
| 3 Month Change | -27.71% |
| 1 Year Change | -51.95% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -62.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| JL6 | DE Health Care REITs | DE Market | |
|---|---|---|---|
| 7D | -2.5% | 0% | 0% |
| 1Y | -52.0% | 0% | 0% |
Return vs Industry: JL6 underperformed the German Health Care REITs industry which returned -13.1% over the past year.
Return vs Market: JL6 underperformed the German Market which returned 5.4% over the past year.
Price Volatility
| JL6 volatility | |
|---|---|
| JL6 Average Weekly Movement | 8.0% |
| Health Care REITs Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in DE Market | 0% |
| 10% least volatile stocks in DE Market | 0% |
Stable Share Price: JL6's share price has been volatile over the past 3 months.
Volatility Over Time: JL6's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Simon Farnsworth | www.lifesciencereit.co.uk |
Life Science REIT plc Fundamentals Summary
| JL6 fundamental statistics | |
|---|---|
| Market cap | €152.57m |
| Earnings (TTM) | -€25.37m |
| Revenue (TTM) | €23.31m |
6.5x
P/S Ratio-6.0x
P/E RatioIs JL6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JL6 income statement (TTM) | |
|---|---|
| Revenue | UK£19.94m |
| Cost of Revenue | UK£6.12m |
| Gross Profit | UK£13.83m |
| Other Expenses | UK£35.53m |
| Earnings | -UK£21.71m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.062 |
| Gross Margin | 69.33% |
| Net Profit Margin | -108.85% |
| Debt/Equity Ratio | 38.0% |
How did JL6 perform over the long term?
See historical performance and comparison